Related Experiment Video
Updated: May 17, 2026

Measurement of the Pressure-volume Curve in Mouse Lungs
Published on: January 27, 2015
Physiological modeling of responses to upper versus lower lobe lung volume reduction in homogeneous emphysema
Arschang Valipour1, Mordechai R Kramer, Franz Stanzel
1Department of Respiratory and Critical Care Medicine, Ludwig-Boltzmann-Institute for COPD, Otto Wagner Hospital Vienna, Austria.
Rationale:
In clinical trials, homogeneous emphysema patients have responded well to upper lobe volume reduction but not lower lobe volume reduction.
Materials/Methods:
To understand the physiological basis for this observation, a computer model was developed to simulate the effects of upper and lower lobe lung volume reduction on RV/TLC and lung recoil in homogeneous emphysema.
Results:
Patients with homogeneous emphysema received either upper or lower lobe volume reduction therapy based on findings of radionucleotide scintigraphy scanning. CT analysis of lobar volumes showed that patients undergoing upper (n = 18; -265 mL/site) and lower lobe treatment (LLT; n = 11; -217 mL/site) experienced similar reductions in lung volume. However, only upper lobe treatment (ULT) improved FEV(1) (+11.1 ± 14.7 versus -4.4 ± 15.8%) and RV/TLC (-5.4 ± 8.1 versus -2.4 ± 8.6%). Model simulations provided an unexpected explanation for this response. Increases in transpulmonary pressure subsequent to volume reduction increased RV/TLC in upper lobe alveoli, while caudal shifts in airway closure decreased RV/TLC in lower lobe alveoli. ULT, which eliminates apical alveoli with high RV/TLC values, lowers the average RV/TLC of the lung. Conversely, LLT, which eliminates caudal alveoli with low RV/TLC values, has less effect.
Conclusion:
LLT in homogeneous emphysema is uniformly less effective than ULT.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease II: Emphysema
Respiratory Volumes
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

